Eli Lilly’s Oral Obesity Pill Approved, Kicking Off Renewed Novo Rivalry

The FDA approved Eli Lilly’s orforglipron—to be known as Foundayo—on Wednesday, officially igniting what analysts believe will be a fierce rivalry with Novo Nordisk’s oral Wegovy.